NCT05649384

Brief Summary

The PRESC1SE-MI study compares two algorithms for triage of patients presenting with chest pain and symptoms of heart attack (myocardial infarction) to the emergency department. Both algorithms are recommended by the European Society of Cardiology: the 0/3-hour algorithm and the 0/1-hour algorithm. Currently, most emergency departments worldwide use the 0/3-hour troponin algorithm. Cardiac troponin (cTn) is a heart-specific biomarker which indicates damage of the heart muscle and which increases after a heart attack. In the 0/3-hour algorithm, the amount of troponin in the bloodstream is measured with a high-sensitivity assay at admission and 3 hours thereafter. Likewise, the 0/1-hour algorithm means that the blood sample in which the troponin is measured is collected at admission and 1 hour later. Since recent clinical studies suggest that the 0/1-hour algorithm is superior to the 0/3-hour algorithm, many hospitals consider switching to the 0/1-hour algorithm. The aim of this study is to assess how feasible the time-saving 0/1-hour algorithm would be in reality and whether it provides the same accuracy and safety in the diagnosis of myocardial infarction as the current practice the 0/3-hour algorithm.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64,374

participants targeted

Target at P75+ for not_applicable

Timeline
25mo left

Started Dec 2020

Longer than P75 for not_applicable

Geographic Reach
10 countries

19 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Dec 2020May 2028

Study Start

First participant enrolled

December 1, 2020

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

November 14, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 14, 2022

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2028

Last Updated

January 27, 2026

Status Verified

January 1, 2026

Enrollment Period

7.1 years

First QC Date

November 14, 2022

Last Update Submit

January 23, 2026

Conditions

Keywords

ESC 0/1-hour algorithmEmergency departmentChest painChest discomfortMyocardial Infarction MIAcute Myocardial Infarction AMIAcute Coronary Syndrome ACSNSTEMI Non-ST-segment elevation myocardial infarctionNSTE-ACS Non-ST-segment elevation acute coronary syndromeUnstable anginaDamaged muscle of the heartCardiac BiomarkersCardiac Troponin T cTnTCardiac-Specific Troponin TCardiac Troponin I cTnICardiac-Specific troponin IAmount of troponin in the bloodstreamIncreased troponin levelElevated troponin levelHigh troponin levelTroponin assessmentMeasurement of troponin levelsHigh-sensitive troponin testHigh-sensitivity troponin T testingHigh-sensitive Troponin T hsTnTcTnT-hsHigh-sensitive Troponin I hsTnIcTnI-hsHigh-sensitivity cardiac troponin assaysED presentationED admissionED work-upTriage emergency departmentTriage emergency roomTriage emergency hospitalRapid Rule-out of Acute Myocardial InfarctionShorter stay in the emergency departmentESC 0/3-hour algorithmESC GuidelinesEuropean Guidelines0/1-hour algorithm0/3-hour algorithm

Outcome Measures

Primary Outcomes (2)

  • Composite of all-cause mortality or new AMI (type 1) occurring within 30 days of index presentation

    Mortality rate and number of newly diagnosed AMI (type 1) in all enrolled patients

    30 days

  • Time from ED presentation to ED discharge or transfer

    Length of stay in the ED measured in hours

    30 days

Secondary Outcomes (13)

  • Proportion of patients managed as outpatients

    24 hours

  • Readmission for suspected AMI within 30 days after index presentation

    30 days

  • All-cause mortality at 30 days in all patients

    30 days

  • All-cause mortality at 365 days in all patients

    365 days

  • New AMI (type1) at 30 days in all patients

    30 days

  • +8 more secondary outcomes

Study Arms (2)

0/1-hour algorithm

EXPERIMENTAL

High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 1 hour later in the emergency department.

Diagnostic Test: European Society of Cardiology hs-cTnT/I 0 h/1 h algorithm

0/3-hour algorithm

ACTIVE COMPARATOR

High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 3 hours later in the emergency department.

Diagnostic Test: European Society of Cardiology hs-cTnT/I 0 h/3 h algorithm

Interventions

High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 1 hour later in the emergency department.

Also known as: 0/1-hour algorithm
0/1-hour algorithm

High-sensitivity cardiac troponin (hs-cTn) blood tests are performed at admission (0 h) and 3 hours later in the emergency department.

Also known as: 0/3-hour algorithm
0/3-hour algorithm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 and above
  • Presentation with acute non-traumatic acute chest pain to the emergency department
  • Suspicion of acute myocardial infarction

You may not qualify if:

  • Terminal kidney failure requiring dialysis
  • Cardiac arrest
  • Cardiogenic shock

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (20)

Baylor St. Luke's Medical Center

Houston, Texas, 77030, United States

Location

St Andrew's War Memorial Hospital Brisbane

Brisbane, Australia

Location

Vienna General Hospital (AKH Wien)

Vienna, Austria

Location

University Central Hospital Helsinki

Helsinki, Finland

Location

Attikon General Hospital Athens

Athens, Greece

Location

Careggi University Hospital Florence

Florence, Italy

Location

Azienda Ospedaliera San Giovanni Addolorata

Roma, Italy

Location

Hospital Città della Salute e della Scienza di Torino

Torino, Italy

Location

Emergency Institute for Cardiovascular Diseases C.C. Iliescu

Bucharest, Romania

Location

Konkuk University Medical Center

Seoul, South Korea

Location

Hospital Clinic Barcelona

Barcelona, Spain

Location

University Hospital October 12 Madrid

Madrid, Spain

Location

University Hospital Ramon y Cajal

Madrid, Spain

Location

Hospital Clínico Universitario Valencia

Valencia, Spain

Location

Kantonsspital Aarau

Aarau, Switzerland

Location

St. Claraspital

Basel, Switzerland

Location

Kantonsspital Luzern

Lucerne, Switzerland

Location

University Hospital Zurich

Zurich, Switzerland

Location

Royal London Hospital

London, United Kingdom

Location

Royal Cornwall Hospitals Treliske

Truro, United Kingdom

Location

Related Publications (1)

  • Boeddinghaus J, Bima P, Crisanti L, Keller DI, Slankamenac K, Christ M, Schuetz P, Wiencierz A, Strebel I, Reinhardt J, Vyshnevska I, Tsao TY, Mahfoud F, Ruggieri MP, Steuer S, Miro O, Harjola VP, Morello F, Nazerian P, Roth D, Zamorano JL, Gannon DE, Pott J, Abubakr MO, Yang HS, Young J, Bicette R, Cuculici A, Bueno H, Sanchis J, Mueller C; PRESC1SE-MI investigators. PRospective evaluation of the European Society of Cardiology 0/1h-algorithm;s safety and efficacy for triage of patients with suspected myocardial infarction (PRESC1SE-MI): Rationale and design of a prospective international multicenter stepped-wedge cluster randomized controlled trial. Am Heart J. 2026 Feb;292:107299. doi: 10.1016/j.ahj.2025.107299. Epub 2025 Oct 31.

MeSH Terms

Conditions

Non-ST Elevated Myocardial InfarctionEmergenciesChest PainMyocardial InfarctionAngina, Unstable

Interventions

Algorithms

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisDisease AttributesPainNeurologic ManifestationsSigns and SymptomsAngina Pectoris

Intervention Hierarchy (Ancestors)

Mathematical Concepts

Study Officials

  • Christian Müller, MD Prof.

    University Hospital, Basel, Switzerland

    PRINCIPAL INVESTIGATOR
  • Jasper Boeddinghaus, MD

    University Hospital, Basel, Switzerland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: prospective stepped-wedge cluster randomised controlled trial, sites are randomly assigned to either early initiation or late initiation of the ESC hs-cTnT/I 0/1h-algorithm and compared to the standard of care ESC hs-cTnT/I 0/3h-algorith
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2022

First Posted

December 14, 2022

Study Start

December 1, 2020

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

May 31, 2028

Last Updated

January 27, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations